Elucid Bioimaging Inc.

Elucid Bioimaging Inc. has 2 AI-enabled medical devices on the FDA list. The first decision was on December 21, 2018 and the most recent on June 17, 2022 (ElucidVivo A.3). Its most common review panel is Radiology (2 devices).